“Despite the challenges we are facing, we have a good plan and are confident that we can execute on it in 2012.”
In short
Integra LifeSciences Holdings Corporation has reported its financial results for the fourth quarter and full year ending December 31, 2011. Excluding the impact of currency exchange rates, revenues increased 5% for the last quarter and full year over 2010.
More detail
Revenue
Total revenues for the fourth quarter were $203.5 million, reflecting an increase of $9.4 million, or 5%, over the fourth quarter of 2010.
Total revenues in the full year of 2011 were $780.1 million, reflecting an increase of $48 million, or 7%, over the full year of 2010.
Income
The Company reported GAAP net income of $4.6 million for the fourth quarter of 2011, compared to GAAP net income of $18.8 million for the fourth quarter of 2010.
The Company reported GAAP net income of $28.0 million for the full year 2011, compared to GAAP net income of $65.7 million 2010.
Income after adjustments (for details refer to financial statements here)
Adjusted earnings (EBITDA) for the fourth quarter of 2011, computed with adjustments to GAAP reporting, was $38.8 million, a decrease of 7% compared to the same period last year.
Adjusted EBITDA for the full year 2011 was $154.7 million, an increase of 2% compared to the full year 2010.
Adjusted EBITDA excluding stock-based compensation for the fourth quarter of 2011 was $41.8 million, a decrease of 9% compared to the same period last year.
Adjusted EBITDA excluding stock-based compensation for the full year 2011 was $168.2 million, an increase of 1% compared to the same period last year.
Outlook for 2012
The Company anticipates revenues for the full year 2012 between $820 million and $835 million, at current exchange rates. This represents an increase of 5% to 7% over 2011 revenue, or an increase of 6% to 8% excluding the effect of foreign exchange rates. The Company expects revenues in the first quarter of 2012 to be between $190 million and $196 million.
Company comments
“Our 2012 guidance is in the range of our preliminary expectations we set forth in early January,” said Peter Arduini, Integra’s President and Chief Executive Officer. “Despite the challenges we are facing, we have a good plan and are confident that we can execute on it in 2012.”
Source: Integra Financial press release here.
published: February 28, 2012 in: Financial, General Surgery, Neuro